Is a serum uric acid level of 386 μmol/L within the normal range?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Serum Uric Acid Level Assessment

A serum uric acid level of 386 μmol/L is above the recommended target of <360 μmol/L and indicates hyperuricemia that requires monitoring and potential intervention. 1

Normal Range and Clinical Significance

  • Serum uric acid levels should be maintained below 360 μmol/L (6 mg/dL) in all patients with gout or hyperuricemia to prevent crystal formation and deposition 1
  • For patients with severe gout (tophi, chronic arthropathy, frequent attacks), a lower target of <300 μmol/L (5 mg/dL) is recommended until clinical remission is achieved 1
  • Traditional "normal ranges" of 3.5-7.2 mg/dL for men and 2.6-6.0 mg/dL for premenopausal women are based on population distributions rather than clinical outcomes 2
  • Your level of 386 μmol/L exceeds the therapeutic target of <360 μmol/L, placing you at increased risk for urate crystal deposition 1

Clinical Implications

  • Hyperuricemia (>360 μmol/L) is associated with:
    • Increased risk of gout development 1
    • Silent monosodium urate crystal deposition that may lead to joint damage even without symptomatic gout 2
    • Higher risk of cardiovascular mortality, particularly in patients with type 2 diabetes 3
    • Potential contribution to kidney disease progression 4
    • Increased prevalence of cardiac conduction defects 5

Monitoring and Management Recommendations

  • Regular monitoring of serum uric acid levels is essential to maintain levels below 360 μmol/L 1

  • If you have diagnosed gout:

    • Urate-lowering therapy should be adjusted to achieve and maintain serum uric acid <360 μmol/L 1
    • All urate-lowering therapies should be started at a low dose and then titrated upward until the target is reached 1
    • Allopurinol is recommended as first-line therapy, starting at 100 mg/day and increasing by 100 mg increments every 2-4 weeks as needed 1
    • Serum uric acid levels <360 μmol/L should be maintained lifelong 1, 6
  • If you don't have gout but have hyperuricemia:

    • Lifestyle modifications are recommended, including weight loss if appropriate, limiting alcohol intake (especially beer and spirits), avoiding sugar-sweetened drinks, and reducing intake of meat and seafood 1
    • Regular monitoring of kidney function is important as hyperuricemia and kidney dysfunction have a bidirectional relationship 4

Important Considerations

  • Serum uric acid may be temporarily lower during acute inflammatory episodes, so a single measurement may not reflect your usual level 1
  • The relationship between hyperuricemia and disease is not limited to crystal deposition but appears to have direct pathophysiological effects even at levels below saturation point 2
  • Renal function should be assessed and monitored regularly in all patients with hyperuricemia 1

Common Pitfalls to Avoid

  • Assuming that absence of gout symptoms means hyperuricemia is benign - silent crystal deposition and other metabolic effects can occur 2
  • Relying on traditional "normal ranges" rather than evidence-based therapeutic targets (<360 μmol/L) 1, 2
  • Failing to consider comorbidities that may be influenced by or contribute to hyperuricemia 1
  • Discontinuing monitoring or treatment once symptoms resolve, as lifelong management is typically required 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Is it time to revise the normal range of serum uric acid levels?

European review for medical and pharmacological sciences, 2014

Research

Relationship of uric acid with progression of kidney disease.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2007

Guideline

Allopurinol Management for Well-Controlled Gout

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.